ALLEGAXIN Trademark

Trademark Overview


On Saturday, March 5, 2022, a trademark application was filed for ALLEGAXIN with the United States Patent and Trademark Office. The USPTO has given the ALLEGAXIN trademark a serial number of 97297474. The federal status of this trademark filing is REGISTERED as of Tuesday, November 21, 2023. This trademark is owned by Shanghai Affinity Biopharmaceutical Co.,Ltd.. The ALLEGAXIN trademark is filed in the Pharmaceutical Products category with the following description:

Biological preparations for the treatment of cancer diseases, cacinoma diseases, malignant diseases, infectious diseases; Chemical preparations for pharmaceutical or medical purposes, namely, for musculo-skeletal disorders, cancer diseases, cacinoma diseases, and malignant diseases; Chemical preparations for pharmaceutical or medical purposes, namely, for cancer; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Medicinal preparations for the treatment of infectious diseases and for use in oncology; Pharmaceutical preparations for suppressing tumors; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical products for the prevention and treatment of cancer; Tumor suppressing agents
allegaxin

General Information


Serial Number97297474
Word MarkALLEGAXIN
Filing DateSaturday, March 5, 2022
Status700 - REGISTERED
Status DateTuesday, November 21, 2023
Registration Number7226028
Registration DateTuesday, November 21, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 24, 2023

Trademark Statements


Goods and ServicesBiological preparations for the treatment of cancer diseases, cacinoma diseases, malignant diseases, infectious diseases; Chemical preparations for pharmaceutical or medical purposes, namely, for musculo-skeletal disorders, cancer diseases, cacinoma diseases, and malignant diseases; Chemical preparations for pharmaceutical or medical purposes, namely, for cancer; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Medicinal preparations for the treatment of infectious diseases and for use in oncology; Pharmaceutical preparations for suppressing tumors; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical products for the prevention and treatment of cancer; Tumor suppressing agents
Translation of Words in MarkThe wording Allegaxin has no meaning in a foreign language.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, March 9, 2022
Primary Code005
First Use Anywhere DateFriday, July 29, 2022
First Use In Commerce DateFriday, July 29, 2022

Trademark Owner History


Party NameShanghai Affinity Biopharmaceutical Co.,Ltd.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressShanghai 201203
CN

Party NameShanghai Affinity Biopharmaceutical Co.,Ltd.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressShanghai 201203
CN

Party NameShanghai Affinity Biopharmaceutical Co.,Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressShanghai 201203
CN

Trademark Events


Event DateEvent Description
Tuesday, November 21, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, November 21, 2023REGISTERED-PRINCIPAL REGISTER
Thursday, October 19, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, October 18, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, September 13, 2023STATEMENT OF USE PROCESSING COMPLETE
Wednesday, August 30, 2023USE AMENDMENT FILED
Friday, September 8, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, August 30, 2023TEAS STATEMENT OF USE RECEIVED
Tuesday, March 21, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 24, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 24, 2023PUBLISHED FOR OPPOSITION
Wednesday, January 4, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, December 16, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, December 16, 2022ASSIGNED TO EXAMINER
Saturday, March 12, 2022TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Saturday, March 12, 2022TEAS VOLUNTARY AMENDMENT RECEIVED
Wednesday, March 9, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, March 9, 2022NEW APPLICATION ENTERED